2/2 The University of Massachusetts, Boston - Dana-Farber/Harvard Cancer Center U54 Comprehensive Partnership for Cancer Disparities Research

总结 马萨诸塞州波士顿大学（UMass Boston）和Dana-Farber/哈佛癌症中心（DF/HCC） 合作伙伴关系为“弥合鸿沟：解决癌症差异差距的创新”做好了准备 研究、教育、外联和基础设施”。我们的目标是开展伙伴关系活动， 研究将弥合癌症差异的鸿沟科学，研究教育和推广，通过 创新的研究，培训和实践，作为在国家和国家一级的翻译模式。的 推进癌症健康公平合作伙伴关系（PACHE）计划本身就是弥合分歧的一个主要例子： 各机构之间建立的伙伴关系加强了代表性不足的人口群体的教育 并为完善的癌症中心提供必要的资源和研究基础设施， 解决癌症差异。 马萨诸塞大学波士顿分校/肝癌伙伴关系的具体目标是：1）推进跨学科伙伴关系 癌症和癌症健康差异研究计划，反映主题“弥合鸿沟”; 2）制定 来自不同人口的学生和受训人员的教育经历通常在 3）促进招聘和留住不同的学者，特别是那些来自 通过利用机构资源，解决代表性不足的人群; 4）弥合研究-社区鸿沟 通过创新平台：建立和参与社区组织网络， 利用传播和实施科学（D&I）的科学现状开展外联活动; 5） 解决数据缺失问题的尖端方法， 基于人口、社区和基因组学的癌症和癌症差异数据集和项目;以及6） 通过加强机构支持和与国家卫生研究院的赠款匹配，促进伙伴关系活动的可持续性- 机制和其他来源的政府，基金会和慈善支持。

SUMMARY The University of Massachusetts Boston (UMass Boston) and Dana-Farber/Harvard Cancer Center (DF/HCC) Partnership is primed for “Bridging the Divides: Innovations to Address Gaps in Cancer Disparities Research, Education, Outreach and Infrastructure.” Our goal is to pursue Partnership activities and research that will bridge the divides in cancer disparities science, research education, and outreach through innovative research, training, and practice, serving as models for translation at the state and national level. The Partnerships to Advance Cancer Health Equity (PACHE) program itself is a prime example of bridged divides: partnerships formed between institutions have enhanced the education of underrepresented population groups and provided well-established cancer centers with the necessary resources and research infrastructure to address cancer disparities. The specific aims of the UMass Boston–DF/HCC Partnership are to: 1) Advance Partnership transdisciplinary cancer and cancer health disparities research programs reflecting the theme “Bridging the Divides”; 2) Develop educational experiences for students and trainees from a diverse population typically underrepresented in biomedical careers; 3) Promote hiring and retention of diverse scholars, particularly those from underrepresented populations, by leveraging institutional resources; 4) Bridge research-community divides through innovative platforms: forming and engaging networks of community-based organizations to advance outreach drawing on state of the science from dissemination and implementation sciences (D&I); 5) Develop cutting-edge approaches to address data-absenteeism, the lack of representation of underserved groups in population-, community-, and genomics-based cancer and cancer disparities datasets and projects; and 6) Promote sustainability of partnership activities by reinforcing institutional support and grant matching with NIH- mechanisms and other sources of government, foundation, and philanthropic support.